After nearly 100 years of development, treatments that bolster the body's immune system to fight cancer are coming of age – ...
Background Cancer survivors often face the risk of developing heart failure (HF) as a result of their previous cancer therapy ...
Explore surgical options for metastatic bladder cancer, including radical cystectomy and metastasectomy. Learn how surgery ...
As new therapies emerge, particularly for non-muscle invasive disease, clinicians and patients are faced with increasingly ...
Dr. Thomas Flaig highlights the importance of multidisciplinary care and clinical trials in guiding personalized bladder ...
A phase 2 study evaluated the efficacy and safety of adding pembrolizumab to trimodal therapy as a bladder-sparing approach for muscle-invasive bladder cancer (MIBC).
A new randomized clinical trial found that men with localized, intermediate‑risk prostate cancer recovered faster and ...
Prostate cancer is one of the most prevalent malignancies in men and remains a leading cause of cancer-related morbidity and mortality worldwide. For many, prostate cancer follows an indolent course, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results